Clinical Trials Browser

Encephalitis, Headache, Hydrocephalus, Normal Pressure, Meningitis, Multiple Sclerosis, Myasthenia Gravis, Seizures, Vestibular Diseases, Guillain-Barre Syndrome, Parkinsonian Disorders, Spondylosis

NCT05045248 2021-09-16

Efficacy of Apraclonidine Eye Drops in the Treatment of Ptosis Secondary to Myasthenia Gravis

Phase 2 Completed

10 enrolled

Myasthenia Gravis

NCT03052751 2021-08-03

Study to Test the Safety, Tolerability and Efficacy of UCB7665 in Subjects With Moderate to Severe Myasthenia Gravis

Phase 2 Completed

43 enrolled 12 charts

Myasthenia Gravis

NCT02100969 2021-06-02

Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis

Phase 2 Completed

23 enrolled 18 charts

Myasthenia Gravis

NCT03049956 2021-01-11

OVEMP in Myasthenia

Phase NA Completed

96 enrolled

Myasthenia Gravis

Clinical Trials

ADAPT NXT

Evaluate the Safety of HBM9161 (HL161) Subcutaneous Injection in Patients With Generalized Myasthenia Gravis

Efficacy of IVIG Versus PLEX in Myasthenic Crisis in Syria.

A Study to Evaluate the Safe and Effective Use of a Zilucoplan Auto-injector by Study Participants With Generalized Myasthenia Gravis

ADAPTSC+

ECU-MG-304

A Study to Test Efficacy and Safety of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis

Psychological Health and Adverse Childhood Experiences in Myasthenia Gravis: Online Mental Health BMI Learning Program

Open-label Study to Evaluate the Safety of Various Dosing Regimens of MuSK-CAART for MuSK Myasthenia Gravis

A Phase 3, Open-label, Crossover Study to Evaluate Self-administration of Rozanolixizumab by Study Participants With Generalized Myasthenia Gravis (gMG)

Acupuncture in Myasthenia Gravis (AcuMG)

Safety And Efficacy Of Tofacitinib In Patients With Refractory Myasthenia Gravis: A Pilot Study

A Single-Center, Randomized, Open-Label, Two-Sequence, Two-Period, Crossover Study Comparing the Pharmacokinetics and Safety of Pyridostigmine Sustained-Release and Immediate-Release Tablets Following Single and Multiple Doses in Healthy Chinese Participants

An Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of Subcutaneous Zilucoplan in Participants With Generalized Myasthenia Gravis Who Were Previously Receiving Intravenous Complement Component 5 Inhibitors

Yogic Breathing Exercise for People With Amyotrophic Lateral Sclerosis

RAISE

Investigation of the Effects of Proprioceptive Neuromuscular Facilitation Exercises in Patients With Myasthenia Gravis

Clinical Trial to Improve the Magnetic Levator Prosthesis

Study of Telitacicept in Generalized Myasthenia Gravis

MG_SCIG

Clinical Trial Comparing Two Non-Surgical Treatments for Severe Blepharoptosis

A Study to Evaluate Rozanolixizumab in Study Participants With Generalized Myasthenia Gravis

Efficacy and Safety of Sugammadex in Thoracoscopy Thymectomy for Chinese Adults With Myasthenia Gravis

DIG-MG

Pilot Study: Use of the Saccadometer to Detect Characteristic Saccadic Peak Velocity in Myasthenia Gravis Patients

A Phase 3 Open-Label Study of Eculizumab in Pediatric Participants With Refractory Generalized Myasthenia Gravis (gMG)

Rinomax

Interval Inspiratory Training and Aerobic Exercise for Muscle Recovery in Myasthenia Gravis Post-Hospitalization

A Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness

Safety and Efficacy Study of Ravulizumab in Adults With Generalized Myasthenia Gravis

Study to Evaluate Amifampridine Phosphate in Patients With MuSK-MG

Medlink

A Study of RVT-1401 in Myasthenia Gravis (MG) Patients

A Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis

ADAPT+

A Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Adults With Generalized Myasthenia Gravis

A Study of TAK-079 in People With Generalized Myasthenia Gravis

A Study to Evaluate the Efficacy, Safety and PD and PK of HBM9161 in MG Patients

MG

ADAPTsc

SCIG-MG

Safety and Efficacy Study of RA101495 in Subjects With Generalized Myasthenia Gravis

Diaphragm Thickness by Ultrasonography in Neurological Disorders

The Efficacy and Safety of Leflunomide or Azathioprine Therapy in Myasthenia Gravis Patients After Expand Thymectomy

ADAPT

Neurology Inpatient Clinical Education Trial

Efficacy of Apraclonidine Eye Drops in the Treatment of Ptosis Secondary to Myasthenia Gravis

Study to Test the Safety, Tolerability and Efficacy of UCB7665 in Subjects With Moderate to Severe Myasthenia Gravis

Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis

OVEMP in Myasthenia